Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
US8288384B2 · kind B2 · utility
7Cited by
18References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2009 |
| Grant date | Oct 16, 2012 |
| Priority date | — |
| Expiry date | Jun 5, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.